tizanidine

Generic: tizanidine

Labeler: phoenix rx llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tizanidine
Generic Name tizanidine
Labeler phoenix rx llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

tizanidine hydrochloride 4 mg/1

Manufacturer
PHOENIX RX LLC

Identifiers & Regulatory

Product NDC 85509-1180
Product ID 85509-1180_3a7b7ba1-4796-0e38-e063-6294a90a44fc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076286
Listing Expiration 2026-12-31
Marketing Start 2002-07-03

Pharmacologic Class

Classes
adrenergic alpha2-agonists [moa] central alpha-2 adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 855091180
Hyphenated Format 85509-1180

Supplemental Identifiers

RxCUI
313413
UNII
B53E3NMY5C

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tizanidine (source: ndc)
Generic Name tizanidine (source: ndc)
Application Number ANDA076286 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 120 TABLET in 1 BOTTLE (85509-1180-1)
  • 28 TABLET in 1 BOTTLE (85509-1180-2)
  • 30 TABLET in 1 BOTTLE (85509-1180-3)
  • 60 TABLET in 1 BOTTLE (85509-1180-6)
  • 90 TABLET in 1 BOTTLE (85509-1180-9)
source: ndc

Packages (5)

Ingredients (1)

tizanidine hydrochloride (4 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3a7b7ba1-4796-0e38-e063-6294a90a44fc", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313413"], "spl_set_id": ["3a7b9b9a-9bf9-0b37-e063-6294a90a1c39"], "manufacturer_name": ["PHOENIX RX LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (85509-1180-1)", "package_ndc": "85509-1180-1", "marketing_start_date": "20250731"}, {"sample": false, "description": "28 TABLET in 1 BOTTLE (85509-1180-2)", "package_ndc": "85509-1180-2", "marketing_start_date": "20250731"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (85509-1180-3)", "package_ndc": "85509-1180-3", "marketing_start_date": "20250731"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (85509-1180-6)", "package_ndc": "85509-1180-6", "marketing_start_date": "20250731"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (85509-1180-9)", "package_ndc": "85509-1180-9", "marketing_start_date": "20250731"}], "brand_name": "Tizanidine", "product_id": "85509-1180_3a7b7ba1-4796-0e38-e063-6294a90a44fc", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "85509-1180", "generic_name": "Tizanidine", "labeler_name": "PHOENIX RX LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA076286", "marketing_category": "ANDA", "marketing_start_date": "20020703", "listing_expiration_date": "20261231"}